Ambu A/S (OTCMKTS:AMBBY) Short Interest Update

Ambu A/S (OTCMKTS:AMBBY) was the recipient of a large growth in short interest during the month of August. As of August 31st, there was short interest totalling 300 shares, a growth of 200.0% from the August 15th total of 100 shares. Based on an average daily trading volume, of 700 shares, the short-interest ratio is presently 0.4 days.

Ambu A/S Price Performance

Shares of Ambu A/S stock remained flat at $18.88 during trading hours on Thursday. The stock had a trading volume of 3 shares, compared to its average volume of 594. The stock’s 50-day moving average is $20.08 and its two-hundred day moving average is $18.46. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.53 and a quick ratio of 1.49. The stock has a market capitalization of $4.44 billion and a PE ratio of 94.40. Ambu A/S has a 1 year low of $9.45 and a 1 year high of $22.65.

Ambu A/S (OTCMKTS:AMBBY) last announced its earnings results on Friday, August 30th. The company reported $0.07 earnings per share for the quarter. The business had revenue of $199.56 million for the quarter. Ambu A/S had a return on equity of 8.21% and a net margin of 8.55%.

About Ambu A/S

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.